Longitudinal Flow Cytometry Identified 'Minimal Residual Disease' (MRD) Evolution Patterns for Predicting the Prognosis of Patients with Transplant-Eligible Multiple Myeloma

Gu Jingli; Liu Junru; Chen Meilan; Huang Beihui; Li Juan

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Longitudinal Flow Cytometry Identified 'Minimal Residual Disease' (MRD) Evolution Patterns for Predicting the Prognosis of Patients with Transplant-Eligible Multiple Myeloma

【24h】

Longitudinal Flow Cytometry Identified 'Minimal Residual Disease' (MRD) Evolution Patterns for Predicting the Prognosis of Patients with Transplant-Eligible Multiple Myeloma

机译：纵向流式细胞术鉴定了“最小的残留疾病”（MRD）演进模式，用于预测移植符合条件多发性骨髓瘤患者的预后

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共1页
作者
Gu Jingli; Liu Junru; Chen Meilan; Huang Beihui; Li Juan;
展开▼
作者单位

Sun Yat Sen Univ Affiliated Hosp 1 Guangzhou Guangdong Peoples R China;

Sun Yat Sen Univ Affiliated Hosp 1 Guangzhou Guangdong Peoples R China;

Sun Yat Sen Univ Affiliated Hosp 1 Guangzhou Guangdong Peoples R China;

Sun Yat Sen Univ Affiliated Hosp 1 Guangzhou Guangdong Peoples R China;

Sun Yat Sen Univ Affiliated Hosp 1 Guangzhou Guangdong Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Longitudinal Flow Cytometry Identified "Minimal Residual Disease" (MRD) Evolution Patterns for Predicting the Prognosis of Patients with Transplant-Eligible Multiple Myeloma [J] . Gu Jingli, Liu Junru, Chen Meilan, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：纵向流式细胞术鉴定了“最小的残留疾病”（MRD）演进模式，用于预测移植符合条件多发性骨髓瘤患者的预后
2. Minimal Residual Disease (MRD) Analysis Using Multiparametric Flow Cytometry (MFC) and Identification of Differences in Subpopulations Using Next Generation Sequencing (NGS) in the Bone Marrow (BM) of Multiple Myeloma (MM) Patients (pts) [J] . Dold Sandra M., Riebl Veronika, Wider Dagmar, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：使用多射出流式细胞术（MFC）的最小残余疾病（MRD）分析，并在多骨髓瘤（MM）骨髓（MM）骨髓（BM）中使用下一代测序（NGS）鉴定群体的差异差异（PTS）
3. Enrichment of circulating myeloma cells by immunomagnetic beads combined with flow cytometry for monitoring minimal residual disease and relapse in patients with multiple myeloma [J] . Wang Ningning, Tesfaluul Nahom, Li Jia, Annals of hematology . 2019,第12期

机译：通过免疫磁珠循环骨髓瘤细胞的富集与流式细胞术相结合，以监测多种骨髓瘤患者的最小残余疾病和复发
4. Measuring Minimal Residual Disease in Multiple Myeloma by LC-MS/MS; A Comparison to Multicolor Flow Cytometry [C] . H. Robert Bergen, Angela Dispenzieri, Surendra Dasari, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：通过LC-MS / MS测量多发性骨髓瘤中的最小残留疾病;与多色流式细胞术的比较
5. Detection and Monitoring of Multiple Myeloma Measurable Residual Disease by High Sensitivity Flow Cytometry [D] . Soh, Kah Teong. 2020

机译：高灵敏度流式细胞术检测和监测多发性骨髓瘤可测量的残留疾病
6. Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy [O] . Evangelos Terpos, Ioannis V. Kostopoulos, Efstathios Kastritis, 2019

机译：新一代流式细胞术检测最小残留疾病对一线治疗后持续完全缓解的多发性骨髓瘤患者的影响
7. Longitudinal Flow Cytometry Identified “Minimal Residual Disease” (MRD) Evolution Patterns for Predicting the Prognosis of Patients with Transplant-Eligible Multiple Myeloma [O] . Jingli Gu, Junru Liu, Meilan Chen, 2018

机译：纵向流式细胞仪鉴定了“最小的残留疾病”（MRD）演化模式，用于预测移植符合符合条件多发性骨髓瘤患者的预后

Longitudinal Flow Cytometry Identified 'Minimal Residual Disease' (MRD) Evolution Patterns for Predicting the Prognosis of Patients with Transplant-Eligible Multiple Myeloma

著录项

引文网络

相似文献

相关主题

期刊订阅